Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
Bioavailability Study Design: Absolute Versus Relative Bioavailability01:27

Bioavailability Study Design: Absolute Versus Relative Bioavailability

Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
Modified-Release Drug Delivery Systems: Bioavailability01:30

Modified-Release Drug Delivery Systems: Bioavailability

Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tracking pesticide accumulation in juvenile Chinook Salmon during outmigration through the Sacramento-San Joaquin River Delta.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Assessing phototaxis behavior in non-resistant and insecticide-resistant populations of Hyalella azteca.

Ecotoxicology (London, England)·2026
Same author

Characterization of insecticide resistance across aquatic arthropods of the California Sacramento River watershed.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Development of a fipronil insecticide response spectrum model for juvenile Chinook salmon (Oncorhynchus tshawytscha).

Environmental pollution (Barking, Essex : 1987)·2025
Same author

Using a critical body residue approach to assess the acute toxicity of a pesticide mixture to juvenile Chinook salmon (Oncorhynchus tshawytscha).

Environmental pollution (Barking, Essex : 1987)·2025
Same author

Development of a response spectrum model for bifenthrin in juvenile Chinook Salmon (Oncorhynchus tshawytscha).

Environmental pollution (Barking, Essex : 1987)·2025

Related Experiment Video

Updated: May 27, 2026

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
11:07

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

A comparison of exposure methods for SPME-based bioavailability estimates.

Amanda D Harwood1, Peter F Landrum, Michael J Lydy

  • 1Fisheries and Illinois Aquaculture Center, 1125 Lincoln Dr., Rm. 173, Department of Zoology, Southern Illinois University Carbondale, IL 62901, USA.

Chemosphere
|November 8, 2011
PubMed
Summary

Polydimethylsiloxane coated solid phase microextraction (SPME) fibers accurately predict bioavailability. Exposure time and method did not significantly affect SPME fiber concentrations at equilibrium, enhancing their environmental assessment versatility.

More Related Videos

Effective Analysis of Human Exposure Conditions with Body-worn Dosimeters in the 2.4 GHz Band
06:43

Effective Analysis of Human Exposure Conditions with Body-worn Dosimeters in the 2.4 GHz Band

Published on: May 2, 2018

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)
13:54

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

Published on: August 18, 2023

Related Experiment Videos

Last Updated: May 27, 2026

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
11:07

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

Effective Analysis of Human Exposure Conditions with Body-worn Dosimeters in the 2.4 GHz Band
06:43

Effective Analysis of Human Exposure Conditions with Body-worn Dosimeters in the 2.4 GHz Band

Published on: May 2, 2018

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)
13:54

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

Published on: August 18, 2023

Area of Science:

  • Environmental Chemistry
  • Analytical Chemistry
  • Ecotoxicology

Background:

  • Polydimethylsiloxane coated solid phase microextraction (SPME) fibers are used to predict bioavailability for various species and compounds.
  • Established methods for SPME-based bioavailability estimates exist, but factors like equilibrium time and exposure regimen require further investigation.
  • Understanding how exposure conditions influence SPME fiber concentrations is crucial for reliable bioavailability assessments.

Purpose of the Study:

  • To investigate the effects of exposure time and exposure method (shaker table vs. co-exposure with test species) on SPME fiber concentrations.
  • To determine if animal densities or fiber number influence SPME fiber concentrations using permethrin.
  • To assess the impact of different exposure conditions on the accuracy of SPME-based bioavailability estimates.

Main Methods:

  • SPME fibers coated with polydimethylsiloxane were exposed to sediment containing permethrin and p,p'-dichlorodiphenyldichloroethylene (DDE).
  • Exposure methods included shaker table systems and co-exposure with different invertebrate species.
  • Experiments varied exposure times, animal densities, and the number of SPME fibers used.

Main Results:

  • Significant differences were observed in the time required for SPME fibers to reach equilibrium depending on the exposure method and species.
  • However, the final SPME fiber concentrations at equilibrium for both permethrin and DDE were similar across different treatments.
  • Neither animal density nor the number of SPME fibers significantly affected the measured fiber concentrations.

Conclusions:

  • SPME fiber concentrations at equilibrium are not significantly affected by exposure conditions such as time, method, animal density, or fiber volume.
  • These findings confirm the robustness and versatility of SPME fibers for environmental bioavailability assessments.
  • SPME technology provides reliable estimates of bioavailability, adaptable to various exposure scenarios in environmental monitoring.